Sitagliptin Devatis 25 mg
Sitagliptin Devatis 25 mg is a medicine authorised by Swissmedic under authorisation number 70219. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 May 2026 and the authorisation is limited until 30 April 2031. ATC code A10BH01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 70219 |
|---|---|
| Name | Sitagliptin Devatis 25 mg |
| Full name | Sitagliptin Devatis 25 mg, Filmtabletten |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BH01 |
| First authorisation | 01 May 2026 |
| Authorisation validity | 30 April 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sitagliptin Devatis 25 mg, Filmtabletten | B | 01 May 2026 |
| 2 | Sitagliptin Devatis 50 mg, Filmtabletten | B | 01 May 2026 |
| 3 | Sitagliptin Devatis 100 mg, Filmtabletten | B | 01 May 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 3 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 4 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 5 | 28 | Tablette(n) | A10BH01 | 07.06.2. | B |
| 6 | 98 | Tablette(n) | A10BH01 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sitagliptin Devatis 25 mg authorised in Switzerland?
Yes. Sitagliptin Devatis 25 mg is authorised by Swissmedic under authorisation number 70219, data as of 01 September 2026. The authorisation is limited until 30 April 2031.
Which dispensing category does Sitagliptin Devatis 25 mg have?
Sitagliptin Devatis 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sitagliptin Devatis 25 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.